- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0042232

About Resonance Specialties Limited
Data last updated:
Resonance Specialties Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Makers Laboratories Ltd.. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 01 June 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L25209MH1989PLC051993. Its GSTIN is 27AAACA9590Q1ZW (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 524218.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹11.54 Cr. It was formerly known as Armour Polymers Ltd and Armour Polymers Pvt Ltd. It is led by directors including Charchit Jain (Whole-Time Director) and Raj Kamal Prasad Verma.
Its last annual general meeting (AGM) was held on 05 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Plot No. 54D Kandivli Industrial Estate Kandivli West, Mumbai, Maharashtra, India – 400067.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹90.25 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹10.27 Cr (net margin 11.4%) and EBITDA of ₹14.1 Cr (EBITDA margin 15.6%). The net worth stands at ₹73.23 Cr (up 14.4% YoY). Total assets are valued at ₹75.63 Cr (up 12.2% YoY).
The company has about 73 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Resonance Specialties. As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹12.15 Cr on record. Court records list 45 cases involving the company, including 34 filed by the company and 11 filed against it; 5 cases are pending. The company has 8 deals on record (6 market trades, 2 acquisitions); the latest was in May 2026. Its 8 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Redwop Chemicals Private Limited with revenue of ₹79.65 Cr. The company has 11 MSME Form 1 returns on record between 2011 and 2024, listing 348 overdue payments to 93 micro and small suppliers.
Resonance Specialties Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0042232). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website resonancesl.com.
Company details
Name history
Resonance Specialties has undergone 2 name changes throughout its history. The company was previously known as Armour Polymers Ltd, and Armour Polymers Pvt Ltd. The current legal name is Resonance Specialties Limited.
| Company Name | Status |
|---|---|
| Resonance Specialties Limited | Current |
| Armour Polymers Ltd | Previous |
| Armour Polymers Pvt Ltd | Previous |
CIN history
Resonance Specialties has one previous CIN (Corporate Identification Number): U25209MH1989PLC051993. The current CIN is L25209MH1989PLC051993, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L25209MH1989PLC051993 | Current |
| U25209MH1989PLC051993 | Previous |
Recognitions & Rankings of Resonance Specialties
Contact details
Resonance Specialties Limited's registered office is in Mumbai, Maharashtra. Its website is resonancesl.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 54D Kandivli Industrial Estate Kandivli West, Mumbai, Maharashtra, India – 400067
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Resonance Specialties Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Resonance Specialties operates one associated brand: Resonance Specialties. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Construction materials are supplied by Resonance Specialties to industry clients. | resonancesl.com |
Business activity
The main business activity of Resonance Specialties is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Resonance Specialties Limited, buy the company report.
Financials of Resonance Specialties Limited
FY 2025-26 filings availableResonance Specialties Limited reported revenue of ₹90.25 Cr (up 16% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 90.25 | 77.81 | 55.30 | 58.82 | 75.76 | 70.29 | 56.14 |
| Revenue growth | +16.0% | +40.7% | -6.0% | -22.4% | +7.8% | +25.2% | - |
| EBITDA | 14.10 | 9.87 | 4.80 | 6.83 | 16.73 | 14.25 | 6.30 |
| EBITDA margin | +15.6% | +12.7% | +8.7% | +11.6% | +22.1% | +20.3% | +11.2% |
| Profit before tax | 14.08 | 8.88 | 3.94 | 6.85 | 16.30 | 14.57 | 6.93 |
| Net profit | 10.27 | 7.07 | 2.94 | 4.99 | 12.32 | 10.53 | 6.65 |
| Net profit margin | +11.4% | +9.1% | +5.3% | +8.5% | +16.3% | +15.0% | +11.9% |
| EPS (₹) | 9.01 | 5.69 | 2.57 | 4.33 | 10.71 | 9.12 | 4.77 |
| Balance sheet | |||||||
| Total assets | 75.63 | 67.42 | 61.74 | 58.04 | 52.13 | 41.56 | 30.94 |
| Net worth | 73.23 | 64.02 | 57.49 | 55.69 | 51.80 | 40.67 | 30.53 |
| Total debt | 2.24 | 3.31 | 4.17 | 2.29 | 0.09 | 0.72 | 0.00 |
| Cash & bank | 0.60 | 0.60 | 2.16 | 4.29 | 8.54 | 5.87 | 2.45 |
| Net working capital | 40.16 | 45.57 | 36.37 | 38.27 | 38.25 | 25.63 | 15.03 |
| Cash flow | |||||||
| Cash from operations | 17.32 | (2.52) | 4.16 | (8.37) | 13.33 | 4.28 | 1.42 |
| Cash from investing | (14.90) | 3.56 | (6.63) | 3.20 | (8.80) | (1.18) | (1.82) |
| Cash from financing | (2.47) | (1.20) | 0.33 | 0.93 | (1.86) | 0.31 | 1.15 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.58 | 24.48 | 22.96 | 21.53 | 21.27 | 24.20 | 18.24 | 18.06 |
| Revenue growth (YoY) | +53.2% | +1.2% | +25.9% | +19.2% | +23.0% | - | - | - |
| Other income | 0.54 | 0.74 | 0.32 | 0.35 | 0.23 | 0.09 | 0.30 | 0.45 |
| Total expenses | 25.12 | 18.83 | 19.51 | 19.17 | 18.72 | 19.98 | 16.34 | 15.71 |
| EBITDA | 7.46 | 5.65 | 3.45 | 2.36 | 2.55 | 4.22 | 1.90 | 2.35 |
| EBITDA margin | +22.9% | +23.1% | +15.0% | +11.0% | +12.0% | +17.4% | +10.4% | +13.0% |
| Depreciation | 0.34 | 0.34 | 0.34 | 0.33 | 0.33 | 0.11 | 0.48 | 0.49 |
| Interest | 0.01 | 0.05 | 0.05 | 0.06 | 0.08 | 0.03 | 0.08 | 0.10 |
| Profit before tax | 7.65 | 6.00 | 3.38 | 2.32 | 2.37 | 4.17 | 1.64 | 2.21 |
| Tax | 1.91 | 1.40 | 0.88 | 0.67 | 0.74 | 1.12 | 0.52 | 0.40 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 32.58 | 24.48 | 22.96 | 21.53 | 21.27 | 24.20 | 18.24 | 18.06 |
| Revenue growth (YoY) | +53.2% | +1.2% | +25.9% | +19.2% | +23.0% | - | - | - |
| Other income | 0.54 | 0.74 | 0.32 | 0.35 | 0.23 | 0.09 | 0.30 | 0.45 |
| Total expenses | 25.12 | 18.83 | 19.51 | 19.17 | 18.72 | 19.98 | 16.34 | 15.71 |
| EBITDA | 7.46 | 5.65 | 3.45 | 2.36 | 2.55 | 4.22 | 1.90 | 2.35 |
| EBITDA margin | +22.9% | +23.1% | +15.0% | +11.0% | +12.0% | +17.4% | +10.4% | +13.0% |
| Depreciation | 0.34 | 0.34 | 0.34 | 0.33 | 0.33 | 0.11 | 0.48 | 0.49 |
| Interest | 0.01 | 0.05 | 0.05 | 0.06 | 0.08 | 0.03 | 0.08 | 0.10 |
| Profit before tax | 7.65 | 6.00 | 3.38 | 2.32 | 2.37 | 4.17 | 1.64 | 2.21 |
| Tax | 1.91 | 1.40 | 0.88 | 0.67 | 0.74 | 1.12 | 0.52 | 0.40 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 90.25 | 77.81 | 55.30 | 58.82 | 75.76 | 70.29 | 56.14 |
| Revenue growth | +16.0% | +40.7% | -6.0% | -22.4% | +7.8% | +25.2% | - |
| Other income | 1.64 | 0.98 | 0.93 | 1.61 | 1.39 | 1.59 | 1.90 |
| Total expenses | 76.15 | 67.94 | 50.50 | 51.99 | 59.03 | 56.04 | 49.84 |
| Employee cost | 5.90 | 5.00 | 4.77 | 4.28 | 4.32 | 3.80 | 3.90 |
| EBITDA | 14.10 | 9.87 | 4.80 | 6.83 | 16.73 | 14.25 | 6.30 |
| EBITDA margin | +15.6% | +12.7% | +8.7% | +11.6% | +22.1% | +20.3% | +11.2% |
| Depreciation | 1.34 | 1.56 | 1.46 | 1.48 | 1.75 | 0.98 | 0.92 |
| Interest | 0.32 | 0.41 | 0.33 | 0.11 | 0.07 | 0.29 | 0.35 |
| Profit before tax | 14.08 | 8.88 | 3.94 | 6.85 | 16.30 | 14.57 | 6.93 |
| Tax | 3.68 | 2.32 | 0.99 | 1.85 | 3.92 | 4.04 | 1.41 |
| Net profit | 10.27 | 7.07 | 2.94 | 4.99 | 12.32 | 10.53 | 6.65 |
| Net profit margin | +11.4% | +9.1% | +5.3% | +8.5% | +16.3% | +15.0% | +11.9% |
| EPS (₹) | 9.01 | 5.69 | 2.57 | 4.33 | 10.71 | 9.12 | 4.77 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 | 11.54 |
| Reserves & surplus | 61.69 | 52.48 | 45.95 | 44.15 | 40.26 | 29.13 | 18.99 |
| Shareholders' funds (net worth) | 73.23 | 64.02 | 57.49 | 55.69 | 51.80 | 40.67 | 30.53 |
| Secured loans | 2.06 | 3.09 | 4.12 | 2.22 | 0.00 | 0.61 | 0.00 |
| Unsecured loans | 0.18 | 0.22 | 0.05 | 0.07 | 0.09 | 0.11 | 0.00 |
| Total debt | 2.24 | 3.31 | 4.17 | 2.29 | 0.09 | 0.72 | 0.00 |
| Total liabilities | 75.63 | 67.42 | 61.74 | 58.04 | 52.13 | 41.56 | 30.94 |
| Assets | |||||||
| Gross block | 50.01 | 49.56 | 55.81 | 51.62 | 44.17 | 45.26 | 42.49 |
| Net block | 20.56 | 21.33 | 22.89 | 19.91 | 13.82 | 15.90 | 14.11 |
| Capital work in progress | 3.68 | 0.56 | 0.32 | 0.44 | 0.44 | 0.04 | 1.84 |
| Investments | 11.57 | 0.00 | 2.81 | 0.00 | 0.12 | 0.75 | 0.10 |
| Inventories | 34.30 | 26.23 | 22.82 | 23.13 | 11.65 | 16.58 | 13.38 |
| Sundry debtors | 13.89 | 22.37 | 13.32 | 12.34 | 8.20 | 9.42 | 6.14 |
| Cash & bank balances | 0.60 | 0.60 | 2.16 | 4.29 | 8.54 | 5.87 | 2.45 |
| Loans & advances | 6.55 | 3.02 | 8.49 | 4.86 | 13.16 | 5.22 | 1.59 |
| Total current assets | 55.34 | 52.22 | 46.79 | 44.62 | 41.55 | 37.09 | 23.56 |
| Total current liabilities | 15.18 | 6.65 | 10.42 | 6.35 | 3.30 | 11.46 | 8.53 |
| Net working capital | 40.16 | 45.57 | 36.37 | 38.27 | 38.25 | 25.63 | 15.03 |
| Total assets | 75.63 | 67.42 | 61.74 | 58.04 | 52.13 | 41.56 | 30.94 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.22 | 0.39 | 4.29 | 8.54 | 5.87 | 2.45 | 1.70 |
| Net cash from operating activities | 17.32 | (2.52) | 4.16 | (8.37) | 13.33 | 4.28 | 1.42 |
| Net cash from investing activities | (14.90) | 3.56 | (6.63) | 3.20 | (8.80) | (1.18) | (1.82) |
| Net cash from financing activities | (2.47) | (1.20) | 0.33 | 0.93 | (1.86) | 0.31 | 1.15 |
| Net change in cash | (0.05) | (0.16) | (2.13) | (4.24) | 2.66 | 3.42 | 0.76 |
| Closing cash | 0.60 | 0.60 | 2.16 | 4.29 | 8.54 | 5.87 | 2.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +16.0% | +40.7% | -6.0% | -22.4% | +7.8% | +25.2% | - |
| EBITDA growth | +42.9% | +105.6% | -29.7% | -59.2% | +17.4% | +126.2% | - |
| PBT growth | +58.6% | +125.4% | -42.5% | -58.0% | +11.9% | +110.3% | +45.9% |
| Net income growth | +45.3% | +140.5% | -41.1% | -59.5% | +17.0% | +58.4% | - |
| Revenue CAGR (3Y) | +15.3% | +0.9% | -7.7% | +1.6% | +22.1% | +25.0% | +18.0% |
| EBITDA CAGR (3Y) | +27.3% | -16.1% | -30.4% | +2.7% | +51.5% | +184.3% | +46.6% |
| Profitability & leverage | |||||||
| Net income margin | +11.5% | +8.4% | +5.3% | +8.5% | +16.3% | +15.0% | +9.8% |
| Return on capital employed | +21.2% | +15.3% | +7.8% | +14.1% | +39.7% | +48.5% | +37.6% |
| Return on net worth | +16.0% | +11.5% | +5.7% | +10.4% | +30.4% | +35.1% | +29.0% |
| Debt / equity | 0.04 | 0.07 | 0.06 | 0.02 | 0.01 | 0.01 | 0.00 |
| Long-term debt / equity | 0.03 | 0.05 | 0.05 | 0.02 | 0.00 | 0.00 | 0.00 |
| Interest cover | 2.51 | 4.93 | 9.88 | 2.06 | 0.47 | 2.19 | 6.51 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.96 | 1.59 | 1.13 | 1.56 | 2.18 | 2.04 | 1.75 |
| Inventory turnover | 2.98 | 3.17 | 2.41 | 3.79 | 6.02 | 5.20 | 5.73 |
| Debtors turnover | 4.98 | 4.36 | 4.31 | 6.41 | 9.65 | 10.01 | 9.30 |
| EPS (₹) | 9.01 | 5.69 | 2.57 | 4.33 | 10.71 | 9.12 | 4.77 |
| Dividend per share (₹) | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Book value per share (₹) | 60.27 | 52.28 | 46.63 | 43.36 | 40.00 | 30.35 | 21.57 |
To see the full year-wise statements and ratios of Resonance Specialties Limited, buy the company report.
Board of directors of Resonance Specialties Limited
Resonance Specialties has 6 current directors and 29 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kamal Prasad Verma Also directs: Makers Laboratories Ltd, Evse Ready India Private Limited, Numantra Technologies Private Limited and 2 more | Director | 10 Nov 2020 | 5 Years 11 Months | Current |
| Charchit Jain Also directs: Kaygee Laboratories Private Limited | Whole-Time Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Ajay Anantrai Patadia Also directs: Mantra Capital Limited, Emerging Fashions Private Limited, Pmi Entertainment (India) Private Limited and 1 more | Director | 27 Jun 2020 | 6 Years 4 Months | Current |
| Prashant Godha | Director | 10 Nov 2020 | 5 Years 11 Months | Current |
| Nilesh Jain Also directs: Makers Laboratories Ltd | Director | 02 Feb 2023 | 3 Years 8 Months | Current |
| Dhara Pratik Shah | Director | 04 Feb 2026 | 0 Years 8 Months | Current |
Peer comparison
Resonance Specialties Limited is compared with the 8 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Resonance Specialties Limitedthis company | ₹90.25 Cr (FY 2026) | ₹10.27 Cr | 11.4% | 16.0% | 73 | Mumbai, Maharashtra, India |
| Redwop Chemicals Private Limited | ₹79.65 Cr (FY 2025) | 15.0% | Rajkot, Gujarat, India | |||
| Vanamali Organics Private Limited | ₹79.39 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Metlok Private Limited | ₹79.36 Cr (FY 2025) | 25.0% | Bommasandra, Karnataka, India | |||
| Nikita Transphase Adducts Pvt Ltd | ₹79.35 Cr (FY 2024) | 1.0% | Mumbai, Maharashtra, India | |||
| Pratap Organics Private Limited | ₹78.04 Cr (FY 2024) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Pacific Organics P.Ltd. | ₹77.85 Cr (FY 2024) | -12.0% | Kalyan, Maharashtra, India | |||
| Jai Aravali Industrial Products Private Limited. | ₹77.11 Cr (FY 2024) | -15.0% | Mumbai, Maharashtra, India | |||
| Anmol Chemicals Private Limited | ₹76.94 Cr (FY 2025) | 43.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Resonance Specialties Limited, buy the company report.
Auditor
Resonance Specialties Limited is audited by Kailash Chand Jain & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kailash Chand Jain & Co | FY 2023 | 112318W |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 54.20%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 45.80%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 54.20% | 54.20% | 54.20% | 54.20% |
| Public | 45.80% | 45.80% | 45.80% | 45.80% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Aug 2021 | 100475478 | Yes Bank Limited | ₹12 Cr | Open | |
| 25 Jul 2016 | 100079156 | Others | ₹9.9 Lakh | Satisfied | |
| 11 Jan 2010 | 10199328 | Others | ₹7.4 Cr | Satisfied | |
| 08 Oct 1994 | 90215410 | Bank of Baroda | ₹3 Cr | Satisfied | |
| 23 Sep 1992 | 90215325 | Bank of Baroda | ₹1.65 Cr | Satisfied |
To see the full charge records of Resonance Specialties Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Resonance Specialties Limited has 8 deals on record (6 market trades, 2 acquisitions); the latest was in May 2026.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2026 | Market trade | ₹79.3 Lakh | Buyer: 129 Wealth Fund |
| May 2026 | Market trade | ₹71.4 Lakh | Buyer: 129 Wealth Fund |
| Sep 2020 | Acquisition | ₹44.73 Cr | Buyer: Makers Laboratories Ltd Seller: Ushma Investments Pvt Ltd , Vista Finance Leasing Private Limited |
| Sep 2020 | Acquisition | ₹26.68 Cr | Buyer: Makers Laboratories Ltd , Kaygee Investments Private Limited Seller: Ushma Investments Pvt Ltd , Vista Finance and Leasing Private Limited |
| Sep 2020 | Market trade | ₹28.8 Lakh | Seller: Vista Finance and Leasing Private Limited |
To see the full deal history of Resonance Specialties Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Resonance Specialties Limited has 45 court cases on record: 34 filed by Resonance Specialties, 11 filed against it. 5 cases are pending and 40 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 2 | 1 |
| High courts | 22 | 8 | 4 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 45)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CHOCL) | Filed by the company against Chemech Laboratories Ltd. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Nasense Labs Pvt Ltd and 3 Others | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Glaxosmithkline Pharmaceuticals Limited and Anr. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Remidex Pharma Pvt Ltd | Disposed |
| Bombay High Court | Court case (CHOL) | Filed by the company against Chemech Laboratories Ltd. | Disposed |
To see the full case history of Resonance Specialties Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Resonance Specialties Limited was last rated by Crisil on 31 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 31 Dec 2020 |
To see the full credit ratings and regulatory alerts of Resonance Specialties Limited, buy the company report.
MSME payment delays
Resonance Specialties Limited has 11 MSME Form 1 returns on record between 2011 and 2024, listing 348 overdue payments to 93 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 93)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Rappid Valves (India) Limited | |||
| Mahi Integrated Logistics | |||
| an individual supplier |
To see the full MSME payment records of Resonance Specialties Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Resonance Specialties Limited has a workforce of 73 employees on its EPFO records as of Mar 25, 2024, across 1 active EPFO establishment.
GST
Resonance Specialties has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACA9590Q1ZW | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Resonance Specialties Limited, buy the company report.
Recent activity
Resonance Specialties Limited has 51 board changes on record since 1991: 29 appointments and 22 cessations. The latest: Dhara Pratik Shah was appointed as Director on 04 Feb 2026.
55 earlier events are in the company report.
News
Frequently asked questions
Resonance Specialties is an active public limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 01 June 1989 (37+ years old) and is registered under CIN L25209MH1989PLC051993. Listed on BSE: 524218.
Resonance Specialties reported revenue of ₹90.25 Cr for FY 2025-26 (up 16% YoY) based on standalone financials.
Resonance Specialties has 6 current directors:
- Charchit Jain - Whole-Time Director
- Raj Kamal Prasad Verma - Director
- Ajay Anantrai Patadia - Director
- Prashant Godha - Director
- Nilesh Jain - Director
- Dhara Pratik Shah - Director
The latest financial statements of Resonance Specialties on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 05 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Resonance Specialties is 27AAACA9590Q1ZW, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Resonance Specialties is L25209MH1989PLC051993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Resonance Specialties is a listed company as per MCA records. Its shares are listed on BSE (code: 524218).
Resonance Specialties has 45 court cases on record: 34 filed by the company and 11 filed against it. 5 are pending. Most are in the district courts.
Resonance Specialties was incorporated on 01 June 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.
Resonance Specialties has 8 deals on record (6 market trades, 2 acquisitions); the latest was in May 2026.
The peers of Resonance Specialties by revenue are Redwop Chemicals Private Limited, Vanamali Organics Private Limited, Metlok Private Limited, Nikita Transphase Adducts Pvt Ltd, Pratap Organics Private Limited and 3 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dhara Pratik Shah was appointed as Director on 04 Feb 2026. Nilesh Jain was appointed as Director on 02 Feb 2023. Ashish Harishbhai Katariya ceased to be Whole-Time Director on 10 Nov 2022. Resonance Specialties has 51 board changes on record in total.

